CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, ...

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...

A vaccine originally designed to protect against Covid-19 has shown unexpected promise in helping the immune system fight ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

A new study suggests that these vaccines might boost the effects of immunotherapy drugs, perhaps by alerting the immune ...

I rate AbbVie stock as a Strong Buy, based on its FDA approval of Rinvoq. Read the latest analysis on the stock here.

A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...

From the Internet to the human genome project to cancer treatments, someone’s research becomes the foundation of everything ...

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...